Avoro Capital Advisors LLC: holdings and changes
Number 80 of the top 100 funds by copy return. Avoro Capital Advisors LLC reported 30 US stocks worth $9.7B for the quarter ending 2026-09-30 and changed 5 new, 0 added, 5 trimmed and 1 sold since 2026-06-30.
Copy return, 4 quarters+37.5%
US 500, same time+14.5%
Size$9.7B
Stocks30
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| UTHR United Therapeutics Corp | 15.41% | $1.5B | 2,755,555 | |
| ASND Ascendis Pharma A/S | 11.87% | $1.2B | 5,050,000 | |
| KRYS Krystal Biotech INC | 9.91% | $961M | 2,888,888 | |
| ARGX Argenx Se | 9.89% | $959M | 1,000,000 | |
| MDGL Madrigal Pharmaceuticals INC | 9.53% | $924M | 1,833,333 | |
| KYMR Kymera Therapeutics INC | 8.62% | $836M | 7,474,747 | |
| ARWR Arrowhead Pharmaceuticals, INC. | TRIM -3% | 7.43% | $720M | 11,000,000 |
| RVMD Revolution Medicines INC | TRIM -7% | 4.54% | $440M | 2,145,000 |
| CYTK Cytokinetics INC. | 3.33% | $323M | 4,900,000 | |
| DFTX Definium Therapeutics INC | 2.77% | $268M | 7,050,000 | |
| GPCR Structure Therapeutics INC | 2.12% | $205M | 6,555,555 | |
| XENE Xenon Pharmaceuticals INC | TRIM -5% | 2.11% | $204M | 5,500,000 |
| VERA Vera Therapeutics INC | 1.88% | $182M | 5,635,000 | |
| QURE Uniqure Nv | 1.68% | $162M | 6,727,777 | |
| CELC Celcuity INC | TRIM -56% | 1.23% | $119M | 1,500,000 |
| TSHA Taysha Gene Therapies INC Com Shs | 1.20% | $116M | 23,888,888 | |
| OCUL Ocular Therapeutix INC | 0.98% | $95M | 12,380,300 | |
| DMRA Damora Therapeutics INC Com Shs | BUY | 0.83% | $80M | 3,783,000 |
| COAG Hemab Therapeutics Hldgs INC | 0.60% | $58M | 1,892,372 | |
| VRDN Viridian Therapeutics INC | 0.53% | $52M | 2,500,000 | |
| SEPN Septerna INC | 0.52% | $51M | 1,300,000 | |
| ABVX Abivax Sa-Adr | BUY | 0.50% | $48M | 488,000 |
| SCTX Scribe Therapeutics INC | BUY | 0.49% | $48M | 2,598,973 |
| SENSEI BIOTHER Sensei Biotherapeutics INC | 0.43% | $42M | 1,410,000 | |
| GHRS Gh Research PLC | 0.43% | $42M | 1,770,000 | |
| Biohaven Pharm Biohaven Pharmaceutical Holding Co. LTD | BUY | 0.38% | $37M | 2,750,000 |
| AVTX Avalo Therapeutics INC | 0.38% | $36M | 2,377,777 | |
| BRVE Braveheart Bio INC | BUY | 0.26% | $25M | 1,255,000 |
| AADI BIOSCIENC Aadi Biosciences INC | 0.11% | $11M | 2,849,402 | |
| LXEO Lexeo Therapeutics INC | TRIM -65% | 0.02% | $2M | 525,000 |
| GALECTO INC Galecto INC | SELL | 0% | was $98M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-06-30 → 2023-09-30 | -5.7% | -3.6% |
| 2023-09-30 → 2023-12-31 | +17.6% | +11.2% |
| 2024-03-31 → 2024-06-30 | +0.5% | +4.0% |
| 2024-06-30 → 2024-09-30 | +2.9% | +5.4% |
| 2024-09-30 → 2024-12-31 | -1.8% | +2.1% |
| 2024-12-31 → 2025-03-31 | -7.6% | -4.6% |
| 2025-03-31 → 2025-06-30 | -3.9% | +10.5% |
| 2025-06-30 → 2025-09-30 | +36.9% | +7.8% |
| 2025-09-30 → 2025-12-31 | +24.2% | +2.4% |
| 2025-12-31 → 2026-03-31 | +3.9% | -4.6% |
| 2026-03-31 → 2026-06-30 | +20.3% | +14.8% |
| 2026-06-30 → 2026-09-30 | -11.5% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP